Categories: FirmInvestment
An early-stage venture firm writing lead checks at the Seed and Series A.
Investors 1
Mentions in press and media 4
| Date | Title | Description |
| 18.04.2025 | Assort Health Secures $26M to Revolutionize Patient Call Management | In the bustling world of healthcare, where time is often a luxury, Assort Health has emerged as a beacon of efficiency. The San Francisco-based company recently secured $26 million in funding, a significant boost to its mission of transform... |
| 16.04.2025 | Assort Health Raises $26M for Specialty-Specific GenAI Platform for Managing Patient Phone Calls | What You Should Know:
– Assort Health, a company specializing in AI solutions for managing patient phone calls in healthcare, has announced a new round of institutional financing co-led by First Round Capital and Chemistry, with continued s... |
| 23.12.2024 | Venture Capital Partners Are Leaving Big Firms in Droves | (Bloomberg) -- Being a venture capital partner is supposed to be a job for life. But in 2024, dozens of investors at some of the most storied firms have quit or been pushed out, the effect of a protracted startup downturn and a broader shif... |
| 23.10.2024 | Alums From Bessemer, A16z And Index Launch New Firm With $350M For Seed And Series A Startups | 3 Shares Email Facebook Twitter LinkedIn
Chemistry, a new early-stage VC firm founded by former Bessemer Venture Partners, Andreessen Horowitz and Index Ventures investors, announced its launch Wednesday with a debut fund of $350 million de... |
Reviews 0
